Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells

Clinical Cancer Research

Volumn 12, Issue 1, 2006, Pages 273-280

  Zou, Wei ^a   Yue, Ping ^a   Lin, Na ^b   He, Min ^a   Zhou, Zhongmei ^a   Lonial, Sagal ^a   Khuri, Fadlo R ^a   Wang, Binghe ^b   Sun, Shi Yong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BORONIC ACID DERIVATIVE; BORTEZOMIB; GLUTATHIONE; PROTEASOME; PROTEASOME INHIBITOR; REACTIVE OXYGEN METABOLITE; TIRON;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG INACTIVATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; BLOTTING, WESTERN; BORONIC ACIDS; CELL CYCLE; CELL LINE, TUMOR; DRUG INTERACTIONS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES;

EID: 31544446367     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0503     Document Type: Article

References (42)

1. Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer 2004;4:349-60.
2. Padayatty SJ, Levine M. New insights into the physiology and pharmacology of vitamin C. CMAJ 2001;164:353-5.
3. Head KA. Ascorbic acid in the prevention and treatment of cancer. Altern Med Rev 1998;3:174-86.
4. Padayatty SJ, Levine M. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity. J Am Coll Nutr 2000;19:423-5.
5. Gottlieb N. Cancer treatment and vitamin C: the debate lingers. J Natl Cancer Inst 1999;91:2073-5.
6. Michel L, Dupuy A, Jean-Louis F, et al. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C). J Invest Dermatol 2003;121:881-93.
7. Nagy B, Mucsi I, Molnar J, Varga A, Thurzo L. Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro. In Vivo 2003;17:289-92.
8. Zhang W, Negoro T, Satoh K, et al. Synergistic cytotoxic action of vitamin C and vitamin K3. Anticancer Res 2001;21:3439-44.
9. Reddy VG, Khanna N, Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing p53. Biochem Biophys Res Commun 2001;282:409-15.
10. Bachleitner-Hofmann T, Gisslinger B, Grumbeck E, Gisslinger H. Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia? Br J Haematol 2001;112:783-6.
11. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996;103:183-9.
12. Song EJ, Yang VC, Chiang CD, Chao CC. Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line. Eur J Pharmacol 1995;292:119-25.
13. Chiang CD, Song EJ, Yang VC, Chao CC. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem J 1994;301:759-64.
14. Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 2003;22:118-23.
15. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol 2003;88:434-9.
16. Sun S-Y Yue P, Shroot B, et al. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 1997;57:4931-9.
17. Sun SY, Yue P, Shroot B, Hong WK, Lotan R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J Cell Physiol 1997;173:279-84.
18. Sun S-Y, Yue P, Wu GS, et al. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene 1999;18:2357-65.
19. Sun SY, Li W, Yue P, Lippman SM, Hong WK, Lotan R. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 1999;59:2493-8.
20. Adams J, Palombella VJ, Sausville EA, et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999;59:2615-22.
21. Gao X, Zhang Y, Wang B. New boronic acid fluorescent reporter compounds II. A naphthalene-based sensor functional at physiological pH. Org Lett 2003;5:4615-8.
22. Springsteen G, Wang B. Alizarin red as a general fluorescent reporter for studying the binding of boronic acids and carbohydrates. Chem Commun (Camb) 2001;17:1608-9.
23. Springsteen G, Wang B. A detailed examination of boronic acid-diol complexation. Tetrahedron 2002;58:5291-300.
24. Ling YH, Liebes L, Zou Y, Perez-Soler R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 2003;278:33714-23.
25. Yu C, Rahmani M, Dent P, Grant S. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. Exp Cell Res 2004;295:555-66.
26. Fribley A, Zeng Q, Wang CY. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 2004;24:9695-704.
27. Johnson TR, Stone K, Nikrad M, et al. The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells. Oncogene 2003;22:4953-63.
28. Sayers TJ, Brooks AD, Koh CY, et al. The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood 2003;102:303-10.
29. An J, Sun YP, Adams J, Fisher M, Belldegrun A, Rettig MB. Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) α, and TNF-related apoptosis-inducing ligand in prostate cancer. Clin Cancer Res 2003;9:4537-45
30. Yin D, Zhou H, Kumagai T, et al. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). Oncogene 2005;24:344-54.
31. Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 1997;89:1191-8.
32. Springsteen G, Wang B. A detailed examination of boronic acid-diol complexation. Tetrahedron 2002;58:5291-300.
33. Lorand JP, Edwards JO. Polyol complexes and structure of the benzeneboronate ion. J Org Chem 1959;24:769.
34. Yang W, Lin L, Wang B. A new type of water-soluble fluorescent boronic acid suitable for construction of polyboronic acids for carbohydrate recognition. Heterocycl Commun 2004;10:383-8.
35. Vissers MC, Lee WG, Hampton MB. Regulation of apoptosis by vitamin C. Specific protection of the apoptotic machinery against exposure to chlorinated oxidants. J Biol Chem 2001;276:46835-40.
36. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004;140:533-7.
37. Wang W, Gao X, Wang B. Boronic acid-based sensors for carbohydrates. Curr Org Chem 2002;6:1285-317.
38. Karnati V, Gao X, Gao S, et al. A selective fluorescent sensor for glucose. Bioorg Med Chem Lett 2002;12:3373-7.
39. Yang W, Fan H, Gao SX, et al. The first fluorescent diboronic acid sensor specific for hepatocellular carcinoma cells expressing sialyl Lewis X. Chem Biol 2004;11:439-48.
40. Yang W, Gao X, Wang N. Boronic acid compounds as potential pharmaceutical agents. Med Res Rev 2003;23:346-68.
41. Yang W, Gao S, Gao X, et al. Diboronic acids as fluorescent probes for cells expressing sialyl Lewis X. Bioorg Med Chem Lett 2002;12:2175-7.
42. Burnett TJ, Peebles HC, Hageman JH. Synthesis of a fluorescent boronic acid which reversibly binds to cell walls and a diboronic acid which agglutinates erythrocytes. Biochem Biophy Res Comm 1980;96:157-62.